Kurt May joins ISCO as senior vice-president
This article was originally published in Scrip
International Stem Cell Corporation has appointed Kurt May senior vice-president. Mr May will be responsible for mergers and acquisitions and development of international collaborations. Prior to joining ISCO, Mr May was a senior executive with GTE Corporation, where he was employed for 23 years.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.